Wang Xiao-Tong, Li De-Gang, Li Lei, Kong Fan-Biao, Pang Li-Ming, Mai Wei
Departments of Gastrointestinal and Peripheral Vascular Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China,
Pathol Oncol Res. 2015 Jan;21(1):19-27. doi: 10.1007/s12253-014-9863-x. Epub 2014 Nov 28.
In lower rectal cancer, postoperative outcome is still subject of controversy between the advocates of abdominoperineal resection (APR) and low anterior resection (LAR). Reports suggest that low anterior resection may be oncologically superior to abdominoperineal excision, although no good evidence exists to support this. Publications were identified which assessed the differences comparing 5-year survival, local recurrence, circumferential resection margin rate, complications and so on. A meta-analysis was performed to clarify the safety and feasibility of the two procedures with several types of outcome measures. A total of 13 studies met the inclusion criteria, and comprised 6,850 cases. Analysis of these data showed that LAR group was highly correlated with 5-year survival (pooled OR = 1.73, 95%CI: 1.30-2.29, P = 0.0002 random-effect). And local recurrence rate of APR group was significantly higher than that in LAR group (pooled OR = 0.63, 95%CI: 0.53-0.75, P < 0.00001 fixed-effect). Also, the circumferential resection margin (CRM) were high involved in APR group than in LAR group. (5 trials reported the data, pooled OR = 0.43, 95%CI: 0.36-0.52, P < 0.00001 fixed-effect). Besides, the incidents of overall complications of APR group was higher compared with LAR group (pooled OR = 0.52, 95%CI: 0.29-0.92, P = 0.03 random-effect). Patients treated by APR have a higher rate of CRM involvement, a higher local recurrence, and poorer prognosis than LAR. And there is evidence that in selected low rectal cancer patients, LAR can be used safely with a better oncological outcome than APR. due to the inherent limitations of the present study, for example, the trails available for this systematic review are limited and the finite retrospective data, future prospective randomized controlled trials will be useful to fully investigate these outcome measures and to confirm this conclusion.
在下段直肠癌中,腹会阴联合切除术(APR)和低位前切除术(LAR)的支持者对于术后结果仍存在争议。报告表明,低位前切除术在肿瘤学方面可能优于腹会阴联合切除术,尽管尚无充分证据支持这一点。研究人员检索了评估5年生存率、局部复发率、环周切缘率、并发症等方面差异的文献。通过荟萃分析,采用多种类型的结局指标来阐明这两种手术的安全性和可行性。共有13项研究符合纳入标准,包含6850例病例。对这些数据的分析表明,LAR组与5年生存率高度相关(合并OR = 1.73,95%CI:1.30 - 2.29,P = 0.0002随机效应)。APR组的局部复发率显著高于LAR组(合并OR = 0.63,95%CI:0.53 - 0.75,P < 0.00001固定效应)。此外,APR组的环周切缘(CRM)受累情况高于LAR组。(5项试验报告了相关数据,合并OR = 0.43,95%CI:0.36 - 0.52,P < 0.00001固定效应)。此外,APR组的总体并发症发生率高于LAR组(合并OR = 0.52,95%CI:0.29 - 0.92,P = 0.03随机效应)。接受APR治疗的患者CRM受累率更高、局部复发率更高且预后比LAR患者更差。有证据表明,在部分低位直肠癌患者中,LAR可以安全使用,其肿瘤学结局比APR更好。由于本研究存在固有局限性,例如,可用于本系统评价的试验有限且回顾性数据有限,未来的前瞻性随机对照试验将有助于全面研究这些结局指标并证实这一结论。